Company Filing History:
Years Active: 2025
Title: Yi-Mei Chang: Innovator in Protein Kinase Inhibition
Introduction: Yi-Mei Chang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target specific protein kinases. His work is crucial for advancing treatments for various diseases.
Latest Patents: Yi-Mei Chang holds a patent for "Heterocyclic pyrazole derivatives as type III receptor tyrosine kinase inhibitors." This innovative compound acts as an inhibitor of protein kinases, specifically targeting Class III RTKs such as FLT3, PDGFRα, c-KIT, and CSF-1R kinases. The compound is designed for the treatment of diseases mediated by these kinases, including cancers, autoimmune diseases, and bone resorptive diseases. The patent outlines a structure that includes stereoisomers, tautomers, and pharmaceutically acceptable salts, enhancing its therapeutic potential.
Career Highlights: Yi-Mei Chang is associated with the Development Center for Biotechnology, where he applies his expertise in drug development and molecular biology. His work focuses on creating effective treatments that can significantly improve patient outcomes in various medical conditions.
Collaborations:
Conclusion: Yi-Mei Chang's innovative work in developing kinase inhibitors represents a significant advancement in biotechnology. His contributions are paving the way for new therapeutic options in the treatment of serious diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.